Perlmutter Cancer Center at NYU Langone announced the creation of a multidisciplinary center to develop approaches to diagnose, treat and prevent pancreatic cancer.
In the absence of the federal funding, cancer research will be leaning on private funders. But few private funders have the freedom to ask fundamental questions—questions whose answers may not have an immediate clinical impact but can dramatically advance scientific knowledge.
